Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Expert Review of Hematology
|
December 12, 2018
Brentuximab vedotin in T-cell lymphoma
Carrie Van Der Weyden, Michael Dickinson, James Whisstock, et al.
Current Oncology Reports
|
March 25, 2018
Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome
Louise Photiou, Carrie van der Weyden, Christopher McCormack, et al.
Journal of Personalized Medicine
|
June 2, 2021
Targeted Approaches to T-Cell Lymphoma
Sean Harrop, Chathuri Abeyakoon, Carrie Van Der Weyden, et al.
Ejhaem
|
May 14, 2025
Assessment of the Tolerability and Optimal Dosing of the Combination of Brentuximab Vedotin and Lenalidomide in Patients With Relapsed or Refractory T-cell Lymphoma: Results of a Single-centre Phase 1 Dose-escalation Study
Carrie van der Weyden, Mathias Bressel, Amit Khot, et al.
Expert Opinion on Investigational Drugs
|
July 13, 2018
IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma
Carrie Van Der Weyden, Martine Bagot, Paul Neeson, et al.
Leukemia & Lymphoma
|
December 25, 2025
Relapsed/refractory mycosis fungoides and Sezary syndrome: biology, clinical manifestations and therapeutic options
Friyana Bhabha, H Miles Prince, Belinda Campbell, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 21, 2021
Advances in Frontline Management of Peripheral T-cell Lymphoma
Chathuri Abeyakoon, Carrie van der Weyden, Sean Harrop, et al.
Cancers
|
October 29, 2020
Role of Haematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma
Chathuri Abeyakoon, Carrie van der Weyden, Sean Harrop, et al.
Expert Review of Clinical Immunology
|
July 14, 2025
Immune pathways, current and potential therapies in Mycosis fungoides and Sezary syndrome
Friyana K Bhabha, Carrie Van Der Weyden, Joshua M L Casan, et al.
The Australasian Journal of Dermatology
|
March 9, 2023
CD30-positive lymphoproliferative disorders-An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre
Friyana K Bhabha, Christopher McCormack, Belinda A Campbell, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Expert Review of Hematology
|
December 12, 2018
Brentuximab vedotin in T-cell lymphoma
Carrie Van Der Weyden, Michael Dickinson, James Whisstock, et al.
Current Oncology Reports
|
March 25, 2018
Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome
Louise Photiou, Carrie van der Weyden, Christopher McCormack, et al.
Journal of Personalized Medicine
|
June 2, 2021
Targeted Approaches to T-Cell Lymphoma
Sean Harrop, Chathuri Abeyakoon, Carrie Van Der Weyden, et al.
Ejhaem
|
May 14, 2025
Assessment of the Tolerability and Optimal Dosing of the Combination of Brentuximab Vedotin and Lenalidomide in Patients With Relapsed or Refractory T-cell Lymphoma: Results of a Single-centre Phase 1 Dose-escalation Study
Carrie van der Weyden, Mathias Bressel, Amit Khot, et al.
Expert Opinion on Investigational Drugs
|
July 13, 2018
IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma
Carrie Van Der Weyden, Martine Bagot, Paul Neeson, et al.
Leukemia & Lymphoma
|
December 25, 2025
Relapsed/refractory mycosis fungoides and Sezary syndrome: biology, clinical manifestations and therapeutic options
Friyana Bhabha, H Miles Prince, Belinda Campbell, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 21, 2021
Advances in Frontline Management of Peripheral T-cell Lymphoma
Chathuri Abeyakoon, Carrie van der Weyden, Sean Harrop, et al.
Cancers
|
October 29, 2020
Role of Haematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma
Chathuri Abeyakoon, Carrie van der Weyden, Sean Harrop, et al.
Expert Review of Clinical Immunology
|
July 14, 2025
Immune pathways, current and potential therapies in Mycosis fungoides and Sezary syndrome
Friyana K Bhabha, Carrie Van Der Weyden, Joshua M L Casan, et al.
The Australasian Journal of Dermatology
|
March 9, 2023
CD30-positive lymphoproliferative disorders-An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre
Friyana K Bhabha, Christopher McCormack, Belinda A Campbell, et al.
Page
of 3